Cirrhoses, Liver
11
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
27%
3 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controlled Trial
Nursing Needs of Patients With Cirrhosis
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)
ProspEXPO : Study of the Associations Between Hepatocellular Carcinoma and Chemical and Psychosocial Environmental EXPOsome
Allopurinol and Pathogenesis of Cirrhosis
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
Comparative Study of Secondary Prophylaxis for SBP
Beta-blockers for Oesophageal Varices
Simvastatin Plus Rifaximin in Decompensated Cirrhosis
Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b